Surrozen, Inc. Form 8-K Summary
Business Context and Reporting Period
Surrozen, Inc. filed a Form 8-K reporting an equity securities repurchase transaction. The report date and earliest event date were December 12, 2022; the repurchase was completed on December 15, 2022. Surrozen is listed on the Nasdaq Capital Market under the symbols SRZN and SRZNW.
Transaction and Key Financial Metrics
- Surrozen repurchased 5,382,499 shares of common stock and warrants to purchase 1,310,496 shares of common stock.
- The aggregate purchase price was approximately $2.7 million.
- The repurchased shares will be returned to authorized and unissued status.
- The repurchased warrants will be cancelled.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
Material Changes Versus the Prior Comparable Period
The filing does not present comparative financial statements or a prior-period analysis. Following the transaction, the Consonance Entities no longer held Surrozen common stock or warrants to purchase Surrozen common stock.
Outlook, Risks, Contingencies, and Unusual Items
The transaction was conducted under a securities purchase agreement with entities affiliated with Consonance Capital Management LP. The filing provides no guidance or operational outlook. Investors should consider the effect of the approximately $2.7 million cash outlay on liquidity and the impact of the share and warrant cancellation on the company’s capital structure; the filing does not provide sufficient information to quantify these effects.
Facts to Verify
- Confirm the final settlement date of December 15, 2022 and the approximately $2.7 million purchase price.
- Verify the number of shares repurchased and returned to authorized and unissued status.
- Verify the number of warrants cancelled and their terms, if relevant.
- Review subsequent filings for the transaction’s effect on cash, shares outstanding, warrant liabilities, and liquidity.